AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 32 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $9,496,000 | -60.2% | 11,813,000 | -62.2% | 0.00% | -72.7% |
| Q1 2020 | $23,866,000 | -39.6% | 31,256,000 | -33.2% | 0.01% | -35.3% |
| Q4 2019 | $39,499,000 | +0.3% | 46,756,000 | -2.1% | 0.02% | -10.5% |
| Q3 2019 | $39,368,000 | +9.7% | 47,756,000 | +6.7% | 0.02% | +18.8% |
| Q2 2019 | $35,898,000 | +37.3% | 44,756,000 | +49.2% | 0.02% | +23.1% |
| Q1 2019 | $26,145,000 | +32.8% | 30,006,000 | +39.6% | 0.01% | +18.2% |
| Q4 2018 | $19,691,000 | +151.4% | 21,500,000 | +186.7% | 0.01% | +266.7% |
| Q3 2018 | $7,834,000 | +51.8% | 7,500,000 | +50.0% | 0.00% | 0.0% |
| Q2 2018 | $5,160,000 | -59.0% | 5,000,000 | -59.0% | 0.00% | -57.1% |
| Q1 2018 | $12,586,000 | -15.2% | 12,200,000 | -29.1% | 0.01% | -22.2% |
| Q4 2017 | $14,844,000 | -52.4% | 17,200,000 | -46.2% | 0.01% | -62.5% |
| Q3 2017 | $31,163,000 | -0.4% | 32,000,000 | -1.5% | 0.02% | -11.1% |
| Q2 2017 | $31,295,000 | – | 32,500,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|